Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 43: 13-17, 1997;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (28)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hong, S. H.
Right arrow Articles by Kim, J. Q
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hong, S. H.
Right arrow Articles by Kim, J. Q
Related Collections
Right arrow Molecular Diagnostics and Genetics
Right arrow Evidence Based Laboratory Medicine and Test Utilization
Right arrow Lipids, Lipoproteins, and Cardiovascular Risk Factors
(Clinical Chemistry. 1997;43:13-17.)
© 1997 American Association for Clinical Chemistry, Inc.


Articles

Association between genetic variations of apo AI-CIII-AIV cluster gene and hypertriglyceridemic subjects

Seung Ho Hong1, Woo Hyun Park2, Chung Choo Lee2, Jung Han Song3 and Jin Q Kim4,a

1 Departments of Molecular Biology and
2 Biology, SRC for Cell Differentiation, Seoul National University, Seoul, Korea.

3 Department of Clinical Pathology, Dankook University Hospital, Cheonan, Korea.

4 Department of Clinical Pathology, Seoul National University Hospital, Seoul, Korea.
a Address correspondence to this author at: Division of Clinical Chemistry, Department of Clinical Pathology, Seoul National University Hospital, 28 Yongon-dong, Chongno-gu, Seoul 110–744, Korea. Fax 82-2-745-6653.

Several studies have suggested that genetic variations of the apolipoprotein (apo) AI-CIII-AIV cluster gene are associated with hyperlipidemia or atherosclerosis. These investigations were carried out mainly with Caucasian groups; there have been few associated studies involving non-Caucasian groups. This study was conducted to elucidate the association between five restriction fragment length polymorphisms (RFLPs) of the apo AI-CIII-AIV cluster gene and Korean hypertriglyceridemic subjects. The rare allele frequencies of the XmnI and SstI polymorphic sites in the patients were significantly higher than those of the control group (P <0.05). These two polymorphic sites had relation to linkage disequilibrium in the hypertriglyceridemic subjects ({Delta} = -0.2733). In addition, S2 allele frequency of the SstI RFLP in Koreans was more frequent than that of Caucasians reported previously. The rare allele of XmnI and SstI polymorphic sites was associated with increased triglyceride concentrations in the hypertriglyceridemic group (P <0.005). Koreans have a much lower prevalence of hyperlipidemia than Caucasians. Nevertheless, this study showed a similar trend with results from Caucasian groups, thereby confirming that genetic variations of the apo AI-CIII-AIV cluster gene are likely to be significant markers for hypertriglyceridemic sub-jects. Thus, RFLP loci of the apo AI-CIII-AIV cluster gene may be a useful genetic marker for clinical or population studies.


Key Words: indexing terms: hypertriglyceridemia • restriction fragment length polymorphism • allele frequency • atherosclerosis




The following articles in journals at HighWire Press have cited this article:


Home page
J. Nutr.Home page
M. A. Ostos, D. Recalde, N. Baroukh, A. Callejo, M. Rouis, G. Castro, and M. M. Zakin
Fructose Intake Increases Hyperlipidemia and Modifies Apolipoprotein Expression in Apolipoprotein AI-CIII-AIV Transgenic Mice
J. Nutr., May 1, 2002; 132(5): 918 - 923.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. C. Jong, M. H. Hofker, and L. M. Havekes
Role of ApoCs in Lipoprotein Metabolism : Functional Differences Between ApoC1, ApoC2, and ApoC3
Arterioscler Thromb Vasc Biol, March 1, 1999; 19(3): 472 - 484.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
H. Esterbauer, E. Hell, F. Krempler, and W. Patsch
Allele-specific Differences in Apolipoprotein C-III mRNA Expression in Human Liver
Clin. Chem., March 1, 1999; 45(3): 331 - 339.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by the American Association for Clinical Chemistry.